Plasmin activates VEGF-C and VEGF-D
- 31 May 2004
- journal article
- Published by Elsevier in International Congress Series
- Vol. 1262, 79-82
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-DJournal of Experimental Medicine, 2003
- Clinicopathological Significance of Vascular Endothelial Growth Factor-C in Breast Carcinoma with Long-Term Follow-UpLaboratory Investigation, 2003
- Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 SignalingJNCI: Journal of the National Cancer Institute, 2002
- Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasisThe EMBO Journal, 2001
- VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNature Medicine, 2001
- Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasisNature Medicine, 2001
- Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent HomodimersJournal of Biological Chemistry, 1999
- The vascular endothelial growth factor family; proteins which guide the development of the vasculatureInternational Journal of Experimental Pathology, 1998
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- Proteolytic processing regulates receptor specificity and activity of VEGF‐CThe EMBO Journal, 1997